Our Year in Review: Insights, outcomes, and highlights that shaped 2025. Read the full report!
Aligning Science Across Parkinson's Logo Text

Protocols Suite — SH-SY5Y / iCell® Neurons / High-Content Imaging

Output Details

Routine maintenance of SH-SY5Y cells and SH-SY5Y lines overexpressing 1K/2K/3K-SNCA in DMEM/F-12 with GlutaMAX, 10% FBS, and 1× Pen/Strep. Differentiation of SH-SY5Y (WT or 3K-SNCA) using retinoic acid (RA) plus BDNF to generate neuron-like cells for downstream assays. Culture of iCell® DopaNeurons with heterozygous SNCA p.A53T (Fujifilm CDI R1109) and isogenic control (R1088) using vendor media; optional 7-day compound treatment with half-medium changes. Short-term (24 h) and extended (7-day) treatments in SH-SY5Y and iCell® neurons. Fixation, permeabilisation, and immunostaining for α-syn, pSer129 α-syn, TFEB, GBA, LAMP1; DAPI nuclear stain; acquisition on Opera Phenix® Plus; analysis in Harmony/Columbus.
Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.